Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Elkins-Sinn was a specialized pharmaceutical company focused on the development and manufacture of generic injectable medications. Originally an independent firm founded in 1967, it became a key division of the A.H. Robins Company in 1974, providing a wide array of essential hospital drugs including anesthetics, anticoagulants, and anti-inflammatories. The company was particularly recognized for its Dosette system, a line of ready-to-use injectable products designed for clinical efficiency and safety. After A.H. Robins was acquired by American Home Products (later Wyeth) in 1989, Elkins-Sinn was merged into ESI Lederle before being sold to West-Ward Pharmaceuticals. Today, its manufacturing heritage and facilities in Cherry Hill, New Jersey, are part of Hikma Pharmaceuticals global operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Elkins Sinn Div Ah Robins.